Dr. Diamandis completed his combined MD/PhD and residency training in neuropathology at the University of Toronto. His graduate work focused on designing high-throughput screening platforms to chemically profile neural precursors. This research resulted in the identification of novel regulators of neural and cancer stem cell function. Following completion of his training in 2016, he was hired as a Neuropathologist at the University Health Network. Here, his research team focuses on using chemical biology, deep learning and mass spectrometry-based proteomics to resolve phenotype-level heterogeneity in different brain and glioblastoma niches.